#533: What’s the Tea on Kratom?

Caring for patients using mitragynine-derived substancesFamiliarize yourself with the differences in mitragynine-derived compounds. Understand how to identify and manage kratom use disorder and withdrawal from mitragynine-derived compounds. We’re joined by Dr. Jonathan Tanawan (Profile).   Claim CME for this episode at curbsiders.vcuhealth.org!By listening to this episode and completing CME, this can be used to count towards the new DEA 8-hr requirement on substance use disorders education.Episodes | Subscribe | Spotify | iTunes | [email protected] | CME!Credits Written and Produced, with  Show Notes, Infographic, and Cover Art by Zina Huxley-Reicher, MD  Hosts: Carolyn Chan, MD. MHS and Zina Huxley-Reicher, MD Reviewer: Kento Sonoda, MD, MPH Showrunner: Carolyn Chan, MD, MHS Technical Production: PodPaste Guest: Jonathan Tanawan, MD Show Segments Intro, disclaimer, guest bio Guest one-liner, Picks of the Week* Case from Kashlak; Definitions Pharmacology of  kratom and other mitragynine-based compounds How to take a mitragynine-specific substance use history Defining a use disorder Withdrawal from kratom  Managing a use disorder with MOUD Legal landscape and regulation  Outro Sponsor: FreedGo to freed.ai and use code FREED50 for fifty dollars off your first month. Sponsor: FigsCurbsiders listeners can get 15% off. Just go to WearFIGS.com and use code FIGSRX.  Sponsor: Continuing Education CompanyVisit CMEmeeting.org/curbsiders and use promo code Curb30 for 30% off all online courses and webcasts.